webleads-tracker

Pharma Compliance Info Interview with Tim McGuire, Director, Global Health Care Professional Reporting, Eli Lilly & Company EFPIA

Interview with Tim McGuire, Director, Global Health Care Professional Reporting, Eli Lilly & Company

Pharma Compliance Info Interview with Tim McGuire, Director, Global Health Care Professional Reporting, Eli Lilly & Company EFPIA   The move across Europe to publically disclose the pharmaceutical industry’s financial interactions with Health Care Professionals (HCPs) and Health Care Organizations (HCOs) will inevitably draw more attention to the relationship between companies and healthcare providers.
While some may be concerned about the potential negative impact of this type of information, the opposite is true, says McGuire.
Disclosure of individual financial relationships between industry and HCPs and HCOs will be a positive force, and further highlight the need and importance of cooperation between industry, academia, clinicians, healthcare organisations and patients’ groups in at least three areas:
– the need for collaboration to foster innovation to bring new and better treatments to patients;
– the need for up to date education to ensure the right medicines are used appropriately;
– as a channel for gaining insights into current treatments and understanding unmet medical needs from both the patient’s and clinician’s perspective.
To read the article by Tim McGuire

Check Also

Pharma Compliance Info Belgique | Arrêté royal portant exécution du Sunshine Act EFPIA

Belgique | Arrêté royal portant exécution du Sunshine Act

PHILIPPE, Roi des Belges, A tous, présents et à venir, Salut. Vu l’article 108 de …

X